Goldman Sees Development Catalyst for Altria Group, Inc. (MO) After FDA Approval of on! PLUS

We not too long ago compiled a listing of the 10 Greatest Lengthy-Time period Investments for Youngsters. Altria Group, Inc. stands tenth among the many finest long-term investments. 

TheFly reported on December 22 that Goldman Sachs analyst Bonnie Herzog highlighted a key constructive catalyst for MO following regulatory progress in its fashionable oral nicotine portfolio. The FDA granted advertising and marketing authorization on December 21, 2025, for six on! PLUS nicotine pouch merchandise manufactured by MO’s subsidiary, Helix Improvements LLC.

This approval, the primary beneath the FDA’s new pilot program for expedited Premarket Tobacco Product Functions (PMTAs), helps Altria Group, Inc. (NYSE:MO)’s “Shifting Past Smoking” technique by providing a differentiated, “soft-bodied” pouch expertise in a number of flavors and strengths (6mg and 9mg), enhancing its competitiveness in opposition to dominant rivals like ZYN.

Jonathan Weiss/Shutterstock.com

Herzog famous that this regulatory milestone may function a significant development driver, positioning the company to broaden its high-margin oral nicotine portfolio. The approval aligns with the corporate’s broader operational pivot towards reduced-risk merchandise whereas sustaining conventional income streams.

In distinction, BofA Securities analyst Lisa Lewandowski maintained a Purchase score on MO however lowered the worth goal to $64 from $66 on December 19, citing evolving client tendencies and strain from the illicit e-vapor market.

Altria Group, Inc. (NYSE:MO) is a serious American tobacco and nicotine merchandise firm headquartered in Richmond, Virginia. It is among the largest producers and entrepreneurs of smokeable and oral tobacco merchandise in the USA, promoting iconic manufacturers similar to Marlboro cigarettes, Black & Gentle cigars, and smokeless merchandise like Copenhagen and Skoal.

Whereas we acknowledge the potential of MO as an funding, we consider sure AI shares supply better upside potential and carry much less draw back danger. In the event you’re on the lookout for a particularly undervalued AI inventory that additionally stands to learn considerably from Trump-era tariffs and the onshoring pattern, see our free report on the finest short-term AI inventory.

READ NEXT: 30 Shares That Ought to Double in 3 Years and 11 Hidden AI Shares to Purchase Proper Now. Disclosure: None.